Equities

Yifeng Pharmacy Chain Co Ltd

603939:SHH

Yifeng Pharmacy Chain Co Ltd

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (CNY)35.00
  • Today's Change-1.67 / -4.55%
  • Shares traded6.11m
  • 1 Year change+22.81%
  • Beta--
Data delayed at least 15 minutes, as of Jun 07 2024.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Yifeng Pharmacy Chain Co Ltd is a China-based company principally engaged in the chain retailing of pharmaceuticals, health products, medical equipment and health-related household convenience products. The Company mainly operates through retailing segment. The Company operates direct pharmaceutical chain stores mainly in provinces (or municipalities), including Hunan, Hubei, Shanghai, Jiangsu, Zhejiang and Jiangxi. The retail products of the Company includes pharmaceuticals, medical equipment, health products, health food, personal care products and maternal and child products. The Company is also engaged in the wholesale business through its subsidiary, Hunan Yifeng Pharmaceutical Co., Ltd.

  • Revenue in CNY (TTM)23.29bn
  • Net income in CNY1.48bn
  • Incorporated2008
  • Employees39.65k
  • Location
    Yifeng Pharmacy Chain Co LtdNo. 68Jinzhou Avenue, Lugu High-Tech ZoneCHANGSHA 410000ChinaCHN
  • Phone+86 73 189953989
  • Fax+86 73 189953989
  • Websitehttp://www.yfdyf.cn/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
AIN Holdings Inc18.09bn524.27m9.59bn10.65k18.141.549.480.530322.68322.6811,135.343,791.571.6513.1730.9636,728,570.004.794.108.126.6614.6315.712.902.680.7907--0.0423.9713.445.9830.20-2.6626.793.71
Create SD Holdings Co Ltd19.04bn642.99m10.41bn4.73k15.761.7112.030.5469213.90213.906,326.441,970.862.148.1032.1887,025,370.007.227.6210.8512.1126.2827.443.383.570.8374--0.0023.018.627.272.626.2619.378.87
Kusuri No Aoki Holdings Co Ltd19.58bn399.40m13.95bn4.46k34.922.6814.140.712491.2991.294,475.411,191.111.567.0042.3894,923,100.003.186.144.609.4927.3528.262.043.660.770465.450.42476.3715.3911.3525.286.927.9012.63
LBX Pharmacy Chain JSC22.54bn958.95m19.38bn40.88k20.212.74--0.86021.641.6438.5312.081.063.6111.24551,261.105.405.7311.2912.9632.7332.335.115.080.479513.190.55733.1811.2118.8318.3516.39-6.6019.16
Welcia Holdings Co Ltd56.30bn1.22bn20.70bn15.29k16.701.868.820.3677127.85127.855,879.161,150.652.246.3720.7379,637,510.004.845.768.2710.2330.4030.812.162.510.550744.990.252923.976.389.33-2.148.712.5910.12
Tsuruha Holdings Inc46.84bn1.25bn21.37bn11.30k16.831.609.740.4563554.77554.7720,729.875,827.221.894.8922.4189,640,290.005.566.038.7510.0130.4229.352.943.160.680338.960.143735.085.947.5818.090.368321.9812.23
Sundrug Co Ltd34.77bn1.35bn21.80bn6.37k15.861.8314.000.627249.06249.066,428.422,164.061.936.4530.71--7.467.8811.3711.5525.1824.863.873.820.7523--0.121538.738.885.0313.324.0127.8411.55
Sugi Holdings Co Ltd34.43bn1.02bn21.94bn8.72k20.551.9413.140.6371121.46121.464,114.141,289.592.016.5218.1885,336,660.005.926.118.999.3030.7430.382.953.210.8443--0.011723.9611.518.7915.644.1412.582.71
Dashenlin Pharmaceutical Group Co Ltd25.34bn1.07bn22.74bn45.47k21.223.12--0.89760.94120.941222.416.411.093.8423.18557,261.804.996.5710.0712.6334.8737.514.585.540.61269.070.577245.6715.4522.5912.6317.0226.516.85
Cosmos Pharmaceutical Corp43.32bn1.15bn23.74bn5.29k20.442.2711.650.5481627.89627.8923,646.835,659.542.329.862,065.50177,071,100.006.167.0210.9613.3719.6520.032.663.180.17841,267.960.045612.249.578.212.776.189.6317.32
MatsukiyoCocokara & Co47.29bn2.42bn43.78bn13.66k17.621.7916.250.9257125.28125.282,447.251,233.951.454.8517.46--7.456.809.758.8734.6333.455.154.571.29--0.038628.177.4912.1629.1115.9029.3811.10
Yifeng Pharmacy Chain Co Ltd23.29bn1.48bn44.83bn39.65k30.264.30--1.921.471.4723.0410.310.97954.0112.79587,438.106.936.9312.8912.4737.7438.737.076.710.920851.860.501226.5613.5926.7211.5727.6625.9333.54
Data as of Jun 07 2024. Currency figures normalised to Yifeng Pharmacy Chain Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

12.92%Per cent of shares held by top holders
HolderShares% Held
Zhong Ou Asset Management Co., Ltdas of 31 Dec 202320.20m2.01%
First Sentier Investors (Australia) IM Ltd.as of 29 Feb 202420.06m1.99%
Perseverance Asset Management LPas of 30 Sep 202318.00m1.79%
T. Rowe Price Hong Kong Ltd.as of 31 Mar 202417.60m1.75%
ICBC Credit Suisse Asset Management Co., Ltd.as of 31 Dec 202312.45m1.24%
Harvest Fund Management Co., Ltd.as of 31 Dec 202310.38m1.03%
First Sentier Investors (UK) IM Ltd.as of 31 May 20249.33m0.93%
Harfor Fund Management Co., Ltd.as of 30 Jun 20237.69m0.77%
FIL Investment Management (Singapore) Ltd.as of 30 Apr 20247.14m0.71%
GF Fund Management Co., Ltd.as of 31 Dec 20237.11m0.71%
More ▼
Data from 30 Jun 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.